LifeStance Health Group, Inc. (LFST) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | |
| Revenue | 1.58B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $1.58B | (m) | (m) |
| 2026-03-31 | (m) | $1.49B | (m) | (m) |
| 2025-12-31 | (m) | $1.42B | (m) | (m) |
| 2025-09-30 | (m) | $1.37B | (m) | (m) |
| 2025-06-30 | (m) | $1.32B | (m) | (m) |
| 2025-03-31 | (m) | $1.28B | (m) | (m) |
| 2024-12-31 | (m) | $1.25B | (m) | (m) |
| 2024-09-30 | (m) | $1.21B | (m) | (m) |
| 2024-06-30 | (m) | $1.16B | (m) | (m) |
| 2024-03-31 | (m) | $1.10B | (m) | (m) |
| 2023-12-31 | (m) | $1.06B | (m) | (m) |
| 2023-09-30 | (m) | $1.00B | (m) | (m) |
| 2023-06-30 | (m) | $959.09M | (m) | (m) |
| 2023-03-31 | (m) | $909.04M | (m) | (m) |
| 2022-12-31 | (m) | $859.54M | (m) | (m) |
| 2022-09-30 | (m) | $630.18M | (m) | (m) |
| 2022-06-30 | (m) | $412.62M | (m) | (m) |
| 2022-03-31 | (m) | $61.41M | (m) | (m) |
| 2021-12-31 | (m) | $1.45M | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $143.27M | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) |
| 2020-05-14 | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $212.52M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |